Table 2 Molecular characterization of MSSA strains isolated from patients
Clonal complex (CC) | spa types (no; %) | agr type | Virulence genes (no; %) | Hospitals (no; %) | Total N (%) |
|---|---|---|---|---|---|
CC8 | t037 (19; 73.1), t030 (7; 26.9) | I | tst (15; 57.7) | H1 (8; 30.8), H2 (6; 23.1), H3 (10; 38.5), H4 (2; 7.6) | 26 (30.5) |
t008 (10; 100) | I | pvl (10; 100) | H1 (4; 40), H2 (2; 20), H3 (4; 40) | 10 (11.8) | |
CC22 | t005 (5; 50), t790 (3; 30), t1869 (2; 20) | I | pvl (5; 50), tst (3; 30) | H1 (4; 40), H2 (6; 60) | 10 (11.8) |
CC30 | t021 (8; 88.9), t318 (1; 11.1) | III | pvl (8; 88.9) | H1 (3; 33.3), H2 (3; 33.3), H3 (2; 22.3), H4 (1; 11.1) | 9 (10.6) |
CC7 | t091 (8; 100) | I | – | H1 (4; 50), H2 (4; 50) | 8 (9.4) |
CC5 | t002 (4; 66.7), t045 (2; 33.3) | II | – | H1 (1; 16.7), H2 (2; 33.3), H3 (1; 16.7), H4 (2; 33.3) | 6 (7.1) |
CC398 | t034 (6; 100) | I | – | H1 (5; 83.3), H3 (1; 16.7) | 6 (7.1) |
CC15 | t084 (4; 80), t491 (1; 20) | II | pvl (4; 80) | H4 (5; 100) | 5 (5.9) |
CC59 | t437 (3; 100) | I | tst (3; 100) | H2 (2; 66.7), H4 (1; 33.3) | 3 (3.5) |
CC45 | t015 (2; 100) | I | – | H3 (2; 100) | 2 (2.3) |